Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated (NYSE: INGR) files a range of reports and disclosure documents with the U.S. Securities and Exchange Commission that provide detailed information about its operations as a global ingredient solutions provider. These SEC filings cover the company’s activities in turning grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for food, beverage, animal nutrition, brewing and industrial markets, and its role as a manufacturer serving customers in more than 120 countries.
Through its periodic reports, such as annual and quarterly filings, Ingredion presents condensed consolidated financial results, segment information and commentary on business drivers. The company’s disclosures reference business groupings like Texture & Healthful Solutions, Food & Industrial Ingredients—U.S./Canada, Food & Industrial Ingredients—LATAM and an All Other category, along with discussions of net sales, operating income and regional performance. These filings also describe factors affecting results, including raw material costs, volume trends and regional demand conditions.
Current reports on Form 8-K provide timely information on material events. Recent 8-K filings have described the approval of new stock repurchase programs, the entry into a Revolving Credit Agreement that replaces a previous credit facility, the announcement of quarterly financial results and the conditional definitive agreement to divest a majority ownership interest in the Pakistan affiliate Rafhan Maize while retaining a minority stake. Other 8-K items address the creation of direct financial obligations, termination of prior agreements and the timing of earnings releases and conference calls.
Investors reviewing Ingredion’s SEC filings can also find information on its capital structure, including revolving credit facilities, leverage and interest coverage covenants, and dividend and share repurchase activity as disclosed in earnings materials and current reports. Filings identify INGR as the trading symbol for Ingredion’s common stock on the New York Stock Exchange and confirm that the company is not classified as an emerging growth company. By using AI-powered tools to summarize and highlight key points from these documents, readers can more quickly understand Ingredion’s financial condition, segment performance, capital resources and significant corporate actions as reported in its SEC filings.
Ingredion Inc director Dwayne Andree Wilson received an award of 380 shares of common stock on March 31, 2026 as part of the company’s annual retainer for outside directors, valued at $112.66 per share. After this grant, he directly holds 28,535.324 shares of common stock. His holdings also include restricted stock units acquired through deemed dividend reinvestment, which vest on the same dates as the underlying RSUs.
Ingredion Inc director Patricia Verduin received a grant of common stock as part of her annual retainer. On this Form 4, she acquired 380 shares of Ingredion common stock at an indicated price of $112.66 per share, classified as a grant or award rather than an open-market purchase.
Following this equity award, Verduin directly holds 3,823 shares of Ingredion common stock. The footnote explains that these shares were issued to the company’s outside directors as part of their regular annual compensation, making this a routine, compensation-related transaction rather than a discretionary market trade.
Ingredion Inc director Jorge A. Uribe reported routine equity compensation in company stock. On March 31, 2026, he received 380 shares of common stock as part of the annual retainer for outside directors at an indicated value of $112.66 per share.
Of this award, 67.26 shares were withheld to cover applicable taxes and a fractional amount of 0.74 shares was settled in cash through an open-market sale. Following these transactions, he held 13,236.8574 shares directly and 6,137 shares indirectly through Cafedan Investments Ltd Trust, which includes restricted stock units acquired through deemed dividend reinvestment.
Tanda Stephan B. reported acquisition or exercise transactions in this Form 4 filing.
Ingredion director Stephan B. Tanda received 380 shares of common stock at $112.66 per share as part of the company’s annual retainer for outside directors. After this grant, he holds 1,937 shares directly and 8,800 shares indirectly through The Tanda Joint Living Trust.
Ingredion Inc director Catherine A. Suever received an equity award of 380 shares of common stock at $112.66 per share on March 31, 2026. According to the disclosure, these shares are issued to outside directors as part of their annual retainer, rather than bought in the open market. Following this grant, she directly holds 6,894.709 common shares, which include restricted stock units acquired through deemed dividend reinvestment that vest on the same dates as the related RSUs.
Ingredion Inc director Victoria Reich received an equity award of company stock. On the reported date, she acquired 380 shares of Ingredion common stock as a grant, valued at $111.92 per share, bringing her direct holdings to 19,985.131 shares.
The award consists of restricted stock units issued as part of the annual retainer for outside directors. These units are payable in stock no earlier than six months after resignation or retirement from the board and no later than ten years after that date, and include RSUs from deemed dividend reinvestment.
KENNY GREGORY B reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc board chairman Gregory B. Kenny received a grant of 346 restricted stock units representing common shares, valued at $111.92 per share, as part of the annual retainer for outside directors. These units are payable in stock no earlier than six months after his resignation or retirement from the board and no later than ten years afterward.
Including this award and RSUs from deemed dividend reinvestment, Kenny now holds a total of 66,655.372 shares and units directly, reflecting routine, compensation-related equity rather than an open-market purchase or sale.
Ingredion Inc director Rhonda L. Jordan received an award of 380 shares of common stock on March 31, 2026, valued at $111.92 per share. This reflects restricted stock units granted as part of the company’s annual retainer for outside directors.
The units are payable in stock no earlier than six months after the director’s resignation or retirement from the board and no later than ten years thereafter. Following this grant, Jordan directly holds a total of 26,916.626 shares, including restricted stock units and units acquired through deemed dividend reinvestment.
Ingredion Inc director David B. Fischer reported an automatic equity grant rather than an open-market trade. He received 380 restricted stock units tied to Ingredion common stock at a reference value of $111.92 per share. Following this award, he owns 19,510.2429 shares directly, including RSUs.
The RSUs are issued as part of the company’s annual retainer for outside directors and are payable in stock no earlier than six months after resignation or retirement and no later than ten years afterward. The total also includes RSUs acquired through deemed dividend reinvestment, which vest on the same dates as the related RSUs.
Magro Charles V. reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Charles V. Magro reported stock-based compensation awards, not open-market trades. He received 380 shares of common stock as a grant at an indicated price of $111.92 per share, increasing his direct common stock holdings to 9,479.802 shares.
He was also credited with 235 phantom stock units, each representing the right to receive one share of common stock, based on deferral of a cash retainer under the company’s Non-Qualified Deferred Compensation Plan. Footnotes explain these include restricted stock units issued as part of the outside directors’ annual retainer and RSUs from deemed dividend reinvestment, highlighting this filing as routine director compensation rather than a buy or sell decision.